VALIDATION OF ANTIBODY RAPID TEST FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 INFECTION IN BETHESDA HOSPITAL YOGYAKARTA

Since March 2020, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection has been around in Indonesia with a case fatality rate was 4.7% on August, 1th 2020. So far, the Real-Time Polymerase Chain Reaction (RT-PCR) method is gold standard for SARS-CoV-2 diagnosis. This method, however, some limitations where it long turnaround time, complicated operations, and high prices. Hence, rapid test kits are now readily available to identify patients. The purpose of this study measure diagnostic performance, including sensitivity, specificity, positive negative predictive value, likelihood ratio or LR antibody if compared RT-PCR suspected patients Bethesda Hospital Yogyakarta. research analytical observational cross-sectional design approach, which data were collected retrospectively. instruments used included e-medical record (ERM), Laboratory Information System (LIS) from We demographic patients, results, results using Standard Q COVID-19 IgM/IgG Combo. obtained 50 showed that Rapid kit 100% sensitivity 74.4% specificity 38.9% 3906 results.